SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is a hot topic as the market anticipates clarity from ongoing White House discussions on the CLARITY Act, sparking intense community debate around stablecoin regulation, the ability to offer yields, and its pivotal role as digital financial infrastructure amid broader crypto market sentiment.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in George Town, Cayman Islands.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is buzzing after receiving conditional approval for its U.S. bank charter and strong recent financial results, fueling community excitement about its potential for significant expansion beyond its dominant Latin American market. Investors are keenly watching its continued customer growth and AI-first strategy, positioning it as a major competitor to established fintech players.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is trending due to its exceptionally active and dedicated community, which is relentlessly building a "permissionless brand" through numerous real-world product initiatives and ongoing celebratory events. This strong conviction and resilience are driving significant momentum, showcasing the project's consistent expansion even amidst challenging market conditions.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending following its 12% global workforce reduction, an effort to streamline operations and move towards profitability, which has ignited widespread community concern and speculation regarding the company's financial stability and potential for bankruptcy amidst struggles in the EV sector.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

CRO is trending as the community debates its future following strategic partnerships, including one for prediction markets, and heightened speculation about a potential Trump Media ETF that could heavily feature the coin. Enthusiasm for institutional interest and ecosystem growth clashes with concerns over dilution and past performance.

Kaspa was fair-launched in November 2021 with no pre-mine, zero pre-sale, and no coin allocations, and is 100 percent community-managed. Kaspa aims to be the world's global sequencer for traditional finance and decentralized crypto markets by utilizing proof-of-work and its BlockDAG consensus protocol, GHOSTDAG. Being the world's fastest proof-of-work network, Kaspa combines five properties: (1) hard money principles, (2) Bitcoin's ethos of security-first fundamentals (boasting a security threshold of fifty percent with significant market hashrate), (3) decentralization from rapid block rate mining, (4) block speeds faster than any PoW or PoS network, and (5) smart contract development through based-rollups without fragmented liquidity. Ushering in all five properties, Kaspa is on track to fulfill Satoshi Nakamoto's vision of a digital medium of exchange while also advancing global layer-one sequencing and minuscule confirmation times dominated by internet latency (cf. chapter 6 of the the paper for some initial benchmarks). The Kaspa implementation includes a lot of cool features and subprotocols including Reachability to query the DAG's topology, Block data pruning (with near-future plans for block header pruning), SPV proofs, and later subnetwork support which will make future implementation of layer 2 solutions much easier.

Kaspa

Kaspa is trending amidst a backdrop of recent positive price movement and strong community belief in its foundational BlockDAG technology as a scalable Proof-of-Work solution. While the project advances its smart contract capabilities, recent delays to their mainnet launch are actively discussed alongside concerns about exchange listings, creating a highly polarized outlook among investors.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday is driving conversation after its co-founder returned as CEO to lead AI transformation, a strategy bolstered by activist investor Elliott Management's significant new stake and endorsement, even as the community remains divided on AI's potential to disrupt SaaS business models following cautious sentiment from recent earnings.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending as its newly launched fibromyalgia drug, Tonmya, shows early commercial traction exceeding expectations and attracts institutional investment. However, community sentiment remains divided between excitement for Tonmya's market access and a cautious view on the company's past dilution history and cash burn.

Venice boasts an innovative approach to generative AI with its unique privacy architecture, access to competitive features including multiple leading open-source LLM models such as DeepSeek R1, PDFs analysis, and image and code generation. An unrestricted AI Characters feature is available with its Pro version, Venice Pro.   VVV is designed to minimize friction and reduce costs for AI agents and developers to access private, reliable, on-demand and perpetual AI inference via Venice.ai's API.

Venice Token

Venice Token is trending as recent token burns and a reduction in its emission rate, coupled with surging platform activity, ignite community discussion around its unique private and uncensored AI capabilities. Enthusiastic investors are actively highlighting its significant upside potential due to a low market cap within the rapidly growing AI sector.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is heavily discussed following claims of impressive performance for its Gemini-II AI chip in edge and defense applications, positioning it as a low-power solution, while simultaneously facing significant allegations of misleading statements and a related class action investigation. The community remains sharply divided over the company's true technological capabilities and market prospects, amidst accusations of pump-and-dump tactics and fundamental flaws.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026

MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026 MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP...

Mereo BioPharma Group plc - Sponsored ADR $MREO Stock Holdings Raised by Aberdeen Group plc

Aberdeen Group plc lifted its stake in shares of Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Free Report) by 82.9% during the 3rd quarter, according to its most recent Form 13F filing...

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO INVESTOR ALERT: Pomerantz Law...

NASDAQ: MREO INVESTOR ALERT: Berger Montague Advises Mereo BioPharma Group PLC (NASDAQ: MREO) Investors of an April 6, 2026 Deadline

NASDAQ: MREO INVESTOR ALERT: Berger Montague Advises Mereo BioPharma Group PLC (NASDAQ: MREO) Investors of an April 6, 2026 Deadline NASDAQ: MREO INVESTOR ALERT: Berger Montague Advises Mereo...

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit PR Newswire NEW...

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO) Short Interest Update

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Get Free Report) saw a large increase in short interest during the month of January. As of January 30th, there was short interest totaling...

Shareholders who lost money in shares of Mereo BioPharma Group PLC (NASDAQ: MREO) should contact Wolf Haldenstein immediately

Shareholders who lost money in shares of Mereo BioPharma Group PLC (NASDAQ: MREO) should contact Wolf Haldenstein immediately Shareholders who lost money in shares of Mereo BioPharma Group PLC...

Mereo BioPharma Group plc Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 6, 2026 to Discuss Your Rights - MREO

Mereo BioPharma Group plc Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 6, 2026 to Discuss Your Rights - MREO Mereo BioPharma Group plc Sued for...

Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649). The company was founded by Denise Vera Scots-Knight, Charles Edward Sermon, Alastair Graham MacKinnon, and John P. Richard in March 10, 2015 and is headquartered in London, the United Kingdom.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.01	--	--	N/A
Q3 '25	-$0.01	-$0.01	-75.01%	MISSED
Q2 '25	-$0.01	-$0.02	-71.42%	MISSED
Q1 '25	-$0.02	-$0.02	12.50%	BEAT
Q4 '24	-$0.01	-$0.01	25.00%	BEAT

MREO
Mereo Biopharma

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest MREO News

MREOMereo Biopharma